For cancer modality, it has been proved to be an anti-apoptotic element by its interaction with p53, the tumor-suppressor protein which then inactivates either its transcriptional-dependent or –independent properties and finally diminishes its apoptotic functions. The gene discussed is TP53; the disease is cancer.